["[Tab] Consolidated Statements of Income (Loss) from Baxter International\n\n[Time]: December 31, 2023 [SEP]\n[row 0]: Net sales [SEP] \n[row 1]: Net sales | $14,813 [SEP] \n[row 2]: Cost of sales | $9,838 [SEP] \n[row 3]: Gross margin | $4,975 [SEP] \n[row 4]: Selling, general and administrative expenses | $3,946 [SEP] \n[row 5]: Research and development expenses | $667 [SEP] \n[row 6]: Goodwill impairments | $\u2014 [SEP] \n[row 7]: Other operating expense (income), net | ($28) [SEP] \n[row 8]: Operating income (loss) | $390 [SEP] \n[row 9]: Interest expense, net | $442 [SEP] \n[row 10]: Other (income) expense, net | $51 [SEP] \n[row 11]: Income (loss) from continuing operations before income taxes | ($103) [SEP] \n[row 12]: Income tax (benefit) expense | ($34) [SEP] \n[row 13]: Income (loss) from continuing operations | ($69) [SEP] \n[row 14]: Income from discontinued operations, net of tax | $2,732 [SEP] \n[row 15]: Net income | $2,663 [SEP] \n[row 16]: Net income attributable to noncontrolling interests | $7 [SEP] \n[row 17]: Net income (loss) attributable to Baxter stockholders | $2,656 [SEP] \n[row 18]: Income (loss) from continuing operations per common share | [SEP] \n[row 19]: Basic | ($0.15) [SEP] \n[row 20]: Diluted | ($0.15) [SEP] \n[row 21]: Income from discontinued operations per common share | [SEP] \n[row 22]: Basic | $5.40 [SEP] \n[row 23]: Diluted | $5.40 [SEP] \n[row 24]: Net Income (loss) per common share | [SEP] \n[row 25]: Basic | $5.25 [SEP] \n[row 26]: Diluted | $5.25 [SEP] \n[row 27]: Weighted-average number of shares outstanding | [SEP] \n[row 28]: Basic | 506 [SEP] \n[row 29]: Diluted | 506 [SEP] \n\n[Time]: December 31, 2022 [SEP]\n[row 0]: Net sales [SEP] \n[row 1]: Net sales | $14,506 [SEP] \n[row 2]: Cost of sales | $9,440 [SEP] \n[row 3]: Gross margin | $5,066 [SEP] \n[row 4]: Selling, general and administrative expenses | $3,859 [SEP] \n[row 5]: Research and development expenses | $602 [SEP] \n[row 6]: Goodwill impairments | $2,812 [SEP] \n[row 7]: Other operating expense (income), net | $36 [SEP] \n[row 8]: Operating income (loss) | ($2,243) [SEP] \n[row 9]: Interest expense, net | $395 [SEP] \n[row 10]: Other (income) expense, net | $12 [SEP] \n[row 11]: Income (loss) from continuing operations before income taxes | ($2,650) [SEP] \n[row 12]: Income tax (benefit) expense | $4 [SEP] \n[row 13]: Income (loss) from continuing operations | ($2,654) [SEP] \n[row 14]: Income from discontinued operations, net of tax | $233 [SEP] \n[row 15]: Net income | ($2,421) [SEP] \n[row 16]: Net income attributable to noncontrolling interests | $12 [SEP] \n[row 17]: Net income (loss) attributable to Baxter stockholders | ($2,433) [SEP] \n[row 18]: Income (loss) from continuing operations per common share | [SEP] \n[row 19]: Basic | ($5.29) [SEP] \n[row 20]: Diluted | ($5.29) [SEP] \n[row 21]: Income from discontinued operations per common share | [SEP] \n[row 22]: Basic | $0.46 [SEP] \n[row 23]: Diluted | $0.46 [SEP] \n[row 24]: Net Income (loss) per common share | [SEP] \n[row 25]: Basic | ($4.83) [SEP] \n[row 26]: Diluted | ($4.83) [SEP] \n[row 27]: Weighted-average number of shares outstanding | [SEP] \n[row 28]: Basic | 504 [SEP] \n[row 29]: Diluted | 504 [SEP] \n\n[Time]: December 31, 2021 [SEP]\n[row 0]: Net sales [SEP] \n[row 1]: Net sales | $12,146 [SEP] \n[row 2]: Cost of sales | $7,426 [SEP] \n[row 3]: Gross margin | $4,720 [SEP] \n[row 4]: Selling, general and administrative expenses | $2,845 [SEP] \n[row 5]: Research and development expenses | $531 [SEP] \n[row 6]: Goodwill impairments | $\u2014 [SEP] \n[row 7]: Other operating expense (income), net | ($6) [SEP] \n[row 8]: Operating income (loss) | $1,350 [SEP] \n[row 9]: Interest expense, net | $193 [SEP] \n[row 10]: Other (income) expense, net | $41 [SEP] \n[row 11]: Income (loss) from continuing operations before income taxes | $1,116 [SEP] \n[row 12]: Income tax (benefit) expense | $83 [SEP] \n[row 13]: Income (loss) from continuing operations | $1,033 [SEP] \n[row 14]: Income from discontinued operations, net of tax | $262 [SEP] \n[row 15]: Net income | $1,295 [SEP] \n[row 16]: Net income attributable to noncontrolling interests | $11 [SEP] \n[row 17]: Net income (loss) attributable to Baxter stockholders | $1,284 [SEP] \n[row 18]: Income (loss) from continuing operations per common share | [SEP] \n[row 19]: Basic | $2.04 [SEP] \n[row 20]: Diluted | $2.01 [SEP] \n[row 21]: Income from discontinued operations per common share | [SEP] \n[row 22]: Basic | $0.52 [SEP] \n[row 23]: Diluted | $0.52 [SEP] \n[row 24]: Net Income (loss) per common share | [SEP] \n[row 25]: Basic | $2.56 [SEP] \n[row 26]: Diluted | $2.53 [SEP] \n[row 27]: Weighted-average number of shares outstanding | [SEP] \n[row 28]: Basic | 502 [SEP] \n[row 29]: Diluted | 508 [SEP]"]